Class II drugs recalls

FDA Class II recalls of drugs, newest first. Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

1,333 recalls published between October 9, 2024 and September 30, 2026. Most common issues: manufacturing practices (cgmp) (522), sterility (264), potency (119), microbial contamination (71).